Brief: SymBio Pharmaceuticals says initiation of phase 3 clinical trial on SyB P-1501

SymBio Pharmaceuticals

13/06/2016 07:40

June 13 (Reuters) - SymBio Pharmaceuticals Ltd  4582.T  : 
     
    * Announces the Phase 3 clinical trial on "SyB P-1501" - a 
drug for patient-controlled short-term management of acute 
postoperative pain during hospitalization, was initiated in 
Japan 
     
    Source text in Japanese: http://goo.gl/0bCE0i 
    Further company coverage: 4582.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))